---
schema_version: "secwatch.filing_event.v1"
accession: "0000944809-22-000046"
form_type: "8-K"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T04:56:12.553380+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OPKO Health reports Q3 net loss of $86.1M as COVID testing revenue collapses

## Summary
- Consolidated revenue $179.7M, down 53% YoY from $385.8M, driven by lower COVID-19 testing.
- Diagnostics revenue $142.8M (vs. $340.1M); BRL processed ~0.2M COVID PCR tests vs 2.2M last year.
- Pharmaceuticals revenue $32.4M (vs. $36.9M); NGENLA royalties began; RAYALDEE sales $6.9M.
- Operating loss $87.8M vs operating income $37.8M; net loss $0.11 per share vs $0.04 income.
- BRL cut >$100M annualized costs; cash and equivalents $180.8M at Sept. 30, 2022.

## SEC filing metadata
- accession: 0000944809-22-000046
- form_type: 8-K
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000094480922000046/0000944809-22-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000094480922000046/opk-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000944809-22-000046
- JSON: https://secwatch.observer/filing/0000944809-22-000046.json
- Plain text: https://secwatch.observer/filing/0000944809-22-000046.txt

## Key facts
- Earnings Releases
  OPKO HEALTH, INC. reported third quarter of 2022 results: revenue Consolidated total revenues for the third quarter of 2022 were $179.7 million, net income Net loss for the third quarter of 2022 was $86.1 million, EPS $0.11 per share.
  - Period: third quarter of 2022
  - Revenue: Consolidated total revenues for the third quarter of 2022 were $179.7 million
  - Net income: Net loss for the third quarter of 2022 was $86.1 million
  - EPS: $0.11 per share
  - Result: reported results
  source text: Net loss for the third quarter of 2022 was $86.1 million, or $0.11 per share, compared with net income of $28.7 million, or $0.04 per diluted share, for the 2021 quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000094480922000046/0000944809-22-000046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.